Jesse J Geiger sold $14M of MEDP
President at Medpace Holdings, Inc.. 23,028 shares at an average of $602.00, traded Oct 27, 2025, filed Oct 29, 2025.
Score components
- +20RolePresident
- +25Trade size$13.9M at market
- +10Share of holdings soldSold 41% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.4%, 3m +2.3%, 6m -29.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001677399-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | MOption exercise Common Stock | +19,460 | $166.73 | $3.2M | 55,963 | Oct 29, 2025 |
| Oct 27, 2025 | SOpen-market sale Common Stock | -19,460 | $605.12 | $12M | 36,503 | Oct 29, 2025 |
| Oct 29, 2025 | MOption exercise Common Stock | +3,568 | $166.73 | $595k | 40,071 | Oct 29, 2025 |
| Oct 29, 2025 | SOpen-market sale Common Stock | -3,568 | $585.00 | $2.1M | 36,503 | Oct 29, 2025 |
| Oct 27, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -19,460 | $0.00 | $0 | 3,568 | Oct 29, 2025 |
| Oct 29, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -3,568 | $0.00 | $0 | 0 | Oct 29, 2025 |
Related signals
Other insiders at Medpace Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $30M 48,667 shares | -13% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $1.6M 2,564 shares | -1% | |
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $27M 43,916 shares | -10% | |
| 55Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $44M 70,901 shares | -14% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $6.7M 10,880 shares | -2% | |
| 50Moderate | MEDPsell Medpace Holdings, Inc. | August J. Troendle President & CEO | $15M 24,741 shares | -5% | |
| 56Moderate | Medpace Holdings, Inc. | August J. Troendle President & CEO | $403k 650 shares | -0% | |
| 60Notable | Medpace Holdings, Inc. | Robert O. Kraft director | $2.4M 3,858 shares | -80% | |
| 65Notable | Medpace Holdings, Inc. | August J. Troendle President & CEO | $2.9M 4,673 shares | -1% | |
| 65Notable | Medpace Holdings, Inc. | August J. Troendle President & CEO | $10.0M 15,978 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.